Brooks Laboratories Ltd

Brooks Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Brooks Laboratories Ltd

₹ 128 -0.86%
11 Jun - close price
brookslabs.net BSE: 533543 NSE: BROOKS
About

Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment[1]

Key Points

Business Overview:[1]
BLL is an EU GMP & ISO 9001:2008 certified manufacturer and marketer of pharmaceutical formulations

Website BSE NSE - BE
  • Market Cap ₹ 377 Cr.
  • Current Price ₹ 128
  • High / Low ₹ 203 / 80.6
  • Stock P/E
  • Book Value ₹ 33.3
  • Dividend Yield 0.00 %
  • ROCE -9.90 %
  • ROE -12.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 3.84 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -6.44%
  • Company has a low return on equity of -21.8% over last 3 years.
  • Working capital days have increased from 41.7 days to 70.7 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
28.46 17.12 18.08 15.30 12.61 15.70 24.32 21.75 17.72 17.93 20.79 20.52 23.32
32.37 25.72 27.30 23.85 16.31 19.61 25.42 25.12 27.25 19.85 24.20 22.02 24.58
Operating Profit -3.91 -8.60 -9.22 -8.55 -3.70 -3.91 -1.10 -3.37 -9.53 -1.92 -3.41 -1.50 -1.26
OPM % -13.74% -50.23% -51.00% -55.88% -29.34% -24.90% -4.52% -15.49% -53.78% -10.71% -16.40% -7.31% -5.40%
0.18 0.03 0.40 0.45 0.03 0.05 0.09 0.16 0.65 0.07 0.20 0.03 0.62
Interest 0.84 0.62 0.63 0.75 0.18 0.17 0.19 0.21 0.27 0.16 0.32 0.28 0.26
Depreciation 1.95 1.98 2.28 2.33 0.44 0.44 0.44 0.43 0.46 0.40 0.43 0.38 0.39
Profit before tax -6.52 -11.17 -11.73 -11.18 -4.29 -4.47 -1.64 -3.85 -9.61 -2.41 -3.96 -2.13 -1.29
Tax % -8.90% -15.85% -32.82% -15.21% 0.00% 0.00% 0.00% 0.78% 0.00% 0.00% 0.00% 0.00% 13.95%
-5.93 -9.40 -7.87 -9.48 -4.29 -4.47 -1.64 -3.88 -9.61 -2.41 -3.96 -2.13 -1.46
EPS in Rs -1.37 -2.63 -1.79 -1.92 -1.64 -1.71 -0.62 -1.48 -3.66 -0.92 -1.51 -0.81 -0.50
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
77.25 91.18 63.20 79.49 82.56
76.68 105.43 92.93 97.40 90.60
Operating Profit 0.57 -14.25 -29.73 -17.91 -8.04
OPM % 0.74% -15.63% -47.04% -22.53% -9.74%
0.68 0.80 0.57 0.96 0.88
Interest 3.10 3.10 2.18 0.84 1.03
Depreciation 7.14 7.35 7.03 1.77 1.60
Profit before tax -8.99 -23.90 -38.37 -19.56 -9.79
Tax % 115.46% -19.21% -19.08% 0.15% 1.84%
-19.38 -19.31 -31.04 -19.59 -9.97
EPS in Rs -7.40 -4.31 -7.97 -7.46 -3.38
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -3%
TTM: 4%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 4%
TTM: 49%
Stock Price CAGR
10 Years: 13%
5 Years: 33%
3 Years: 10%
1 Year: 55%
Return on Equity
10 Years: %
5 Years: %
3 Years: -22%
Last Year: -12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 24.70 24.70 24.70 26.25 29.46
Reserves 54.45 62.79 49.25 39.34 68.65
31.38 25.26 6.51 5.64 7.58
51.55 83.16 29.14 19.21 18.00
Total Liabilities 162.08 195.91 109.60 90.44 123.69
107.56 110.01 15.01 13.67 13.98
CWIP 0.83 15.11 0.00 0.00 0.00
Investments 0.02 0.06 64.03 42.91 73.55
53.67 70.73 30.56 33.86 36.16
Total Assets 162.08 195.91 109.60 90.44 123.69

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
4.46 -37.44 -14.49 -9.68 2.52
-5.13 -24.91 0.49 0.18 -45.97
1.16 64.07 11.41 9.60 43.36
Net Cash Flow 0.49 1.72 -2.58 0.10 -0.08

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 64.73 70.69 73.64 74.94 88.38
Inventory Days 177.86 156.51 79.89 60.49 62.10
Days Payable 233.26 159.24 165.21 97.25 91.94
Cash Conversion Cycle 9.34 67.96 -11.69 38.18 58.54
Working Capital Days -4.77 94.51 -3.35 57.81 70.74
ROCE % -15.50% -30.45% -24.70% -9.90%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
66.41% 66.41% 66.41% 66.41% 66.41% 63.59% 63.59% 63.59% 63.59% 63.59% 59.06% 52.62%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.01% 0.05%
0.00% 0.00% 0.00% 0.00% 0.00% 2.46% 3.86% 3.86% 3.86% 3.86% 3.86% 10.38%
33.59% 33.58% 33.59% 33.59% 33.58% 33.94% 32.56% 32.55% 32.55% 32.53% 37.08% 36.95%
No. of Shareholders 11,10410,52410,41010,70911,21610,68610,02811,43211,54311,28210,52110,537

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings